These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 6320197

  • 1. Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus.
    Belardelli F, Vignaux F, Proietti E, Gresser I.
    Proc Natl Acad Sci U S A; 1984 Jan; 81(2):602-6. PubMed ID: 6320197
    [Abstract] [Full Text] [Related]

  • 2. Mouse peritoneal cells confer an antiviral state on mouse cell monolayers: role of interferon.
    Proietti E, Gessani S, Belardelli F, Gresser I.
    J Virol; 1986 Feb; 57(2):456-63. PubMed ID: 3003378
    [Abstract] [Full Text] [Related]

  • 3. Studies on the mechanism of the interferon-mediated antiviral state to vesicular stomatitis virus in resting mouse peritoneal macrophages.
    Di Francesco P, Coccia EM, Gessani S, Romeo G, Borghi P, Locardi C, Belardelli F.
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1899-905. PubMed ID: 2544669
    [Abstract] [Full Text] [Related]

  • 4. Correlation between the lipopolysaccharide response of mice and the capacity of mouse peritoneal cells to transfer an antiviral state. Role of endogenous interferon.
    Gessani S, Belardelli F, Borghi P, Boraschi D, Gresser I.
    J Immunol; 1987 Sep 15; 139(6):1991-8. PubMed ID: 3040861
    [Abstract] [Full Text] [Related]

  • 5. Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons.
    Belardelli F, Gessani S, Proietti E, Locardi C, Borghi P, Watanabe Y, Kawade Y, Gresser I.
    J Gen Virol; 1987 Aug 15; 68 ( Pt 8)():2203-12. PubMed ID: 3039046
    [Abstract] [Full Text] [Related]

  • 6. Injection of mice with antibody to mouse interferon alpha/beta decreases the level of 2'-5' oligoadenylate synthetase in peritoneal macrophages.
    Gresser I, Vignaux F, Belardelli F, Tovey MG, Maunoury MT.
    J Virol; 1985 Jan 15; 53(1):221-7. PubMed ID: 2981340
    [Abstract] [Full Text] [Related]

  • 7. Effects of different biological response modifiers on interferon expression in bacterial lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive mouse peritoneal macrophages.
    Di Marzio P, Gessani S, Locardi C, Borghi P, Baglioni C, Belardelli F.
    J Gen Virol; 1990 Nov 15; 71 ( Pt 11)():2585-91. PubMed ID: 1701475
    [Abstract] [Full Text] [Related]

  • 8. Cyclic AMP-mediated inhibition of vesicular stomatitis virus and herpes simplex virus replication in mouse macrophage-like cells.
    Borghi P, Di Marzio P, Varano B, Conti L, Belardelli F, Gessani S.
    J Gen Virol; 1992 Nov 15; 73 ( Pt 11)():2949-54. PubMed ID: 1279103
    [Abstract] [Full Text] [Related]

  • 9. Regulation of macrophage growth and antiviral activity by interferon-gamma.
    Goldberg M, Belkowski LS, Bloom BR.
    J Cell Biol; 1989 Sep 15; 109(3):1331-40. PubMed ID: 2549078
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acquisition of susceptibility to vesicular stomatitis virus infection by murine resident peritoneal cells during culturing in vitro.
    Orzechowska B, Błach-Olszewska Z.
    Arch Immunol Ther Exp (Warsz); 1996 Sep 15; 44(5-6):325-8. PubMed ID: 9017147
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages.
    Puddu P, Fantuzzi L, Borghi P, Varano B, Rainaldi G, Guillemard E, Malorni W, Nicaise P, Wolf SF, Belardelli F, Gessani S.
    J Immunol; 1997 Oct 01; 159(7):3490-7. PubMed ID: 9317148
    [Abstract] [Full Text] [Related]

  • 15. Macrophages from endotoxin-hyporesponsive (Lpsd) C3H/HeJ mice are permissive for vesicular stomatitis virus because of reduced levels of endogenous interferon: possible mechanism for natural resistance to virus infection.
    Vogel SN, Fertsch D.
    J Virol; 1987 Mar 01; 61(3):812-8. PubMed ID: 2433468
    [Abstract] [Full Text] [Related]

  • 16. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis.
    Fensterl V, Wetzel JL, Ramachandran S, Ogino T, Stohlman SA, Bergmann CC, Diamond MS, Virgin HW, Sen GC.
    PLoS Pathog; 2012 Mar 01; 8(5):e1002712. PubMed ID: 22615570
    [Abstract] [Full Text] [Related]

  • 17. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus.
    Anderson SL, Carton JM, Lou J, Xing L, Rubin BY.
    Virology; 1999 Mar 30; 256(1):8-14. PubMed ID: 10087221
    [Abstract] [Full Text] [Related]

  • 18. Activation of mouse lymphocytes by vesicular stomatitis virus.
    Goodman-Snitkoff GW, McSharry JJ.
    J Virol; 1980 Sep 30; 35(3):757-65. PubMed ID: 6252336
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain.
    Carter CC, Gorbacheva VY, Vestal DJ.
    Arch Virol; 2005 Jun 30; 150(6):1213-20. PubMed ID: 15717119
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.